ESMO 2023 | Managing treatment toxicity when administering immunotherapies in patients with metastatic UC

Enrique Grande, MD, PhD, MD Anderson Cancer Centre Madrid, Madrid, Spain, discusses how associated toxicities can be managed in patients receiving immunotherapies for the treatment of metastatic urothelial carcinoma. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.